Skip to main content
PMC home page
Molecular Pathology : MP logoLink to Molecular Pathology : MP
. 1999 Jun;52(3):146–150. doi: 10.1136/mp.52.3.146

Molecular detection of c-mpl thrombopoietin receptor gene expression in chronic myeloproliferative disorders.

S Duensing 1, A Duensing 1, J G Meran 1, A Kreft 1, G Büsche 1, A Ganser 1, A Georgii 1
PMCID: PMC395689  PMID: 10621836

Abstract

BACKGROUND: Chronic myeloproliferative disorders (CMPD) originate from a pluripotent haematopoietic progenitor cell but show a marked degree of heterogeneity, especially between Philadelphia chromosome positive and negative disease entities. Abnormal megakaryopoiesis is a frequent finding in CMPD, often associated with thrombocythaemic cell counts. Recent experimental data have suggested that the c-Mpl thrombopoietin receptor, together with its ligand thrombopoietin, are not only the major physiological regulators of megakaryopoiesis and platelet production, but also play a crucial role in chronic myeloproliferation. METHODS: A total of 18 peripheral blood mononuclear cell samples obtained from patients with CMPD (chronic myelocytic leukaemia (CML), n = 10; polycythaemia vera (PV), n = 6; and primary thrombocythaemia (PTH), n = 2) were analysed for c-mpl mRNA using the reverse transcriptase polymerase chain reaction (RTPCR). In another 20 patients (CML, n = 10; chronic megakaryocytic granulocytic myelosis (CMGM), n = 3; PV, n = 3; PTH, n = 4), we compared the number of haematopoietic progenitors expressing c-Mpl, as characterised by coexpression with the CD34 antigen, in the bone marrow using double immunofluorescence staining. RESULTS: c-mpl mRNA was detected in all samples from patients with CML analysed, whereas only two of six PV and one of two PTH samples were positive (p < or = 0.008; chi 2 test). Expression of the c-mpl receptor gene was absent in healthy subjects used as controls. Similarly, an increase of c-Mpl expressing CD34 positive haematopoietic cells was detected in seven of 10 bone marrow aspirates obtained from patients with CML. Increased numbers of c-Mpl positive CD34 positive cells were found in only one of four patients with PTH, whereas in PV and CMGM the numbers of c-Mpl positive CD34 positive cells did not exceed normal values, despite thrombocythaemic cell counts. CONCLUSIONS: These data confirm recent findings showing an impaired expression of the c-mpl thrombopoietin receptor gene in Philadelphia chromosome negative CMPD when compared with patients with Philadelphia chromosome positive CML. The relevance of this observation to the functional and morphological characteristics of abnormal megakaryopoiesis remains unclear. Thrombocythaemic cell counts and a mature phenotype in megakaryocytes occur frequently in Philadelphia chromosome negative CMPD but require an intact c-Mpl receptor under physiological conditions. Therefore, further studies are warranted to elucidate the mechanisms contributing to megakaryopoiesis in CMPD disease entities with decreased c-mpl gene expression.

Full Text

The Full Text of this article is available as a PDF (174.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander W. S., Metcalf D., Dunn A. R. Point mutations within a dimer interface homology domain of c-Mpl induce constitutive receptor activity and tumorigenicity. EMBO J. 1995 Nov 15;14(22):5569–5578. doi: 10.1002/j.1460-2075.1995.tb00244.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Battegay E. J., Thomssen C., Nissen C., Gudat F., Speck B. Endogenous megakaryocyte colonies from peripheral blood in precursor cell cultures of patients with myeloproliferative disorders. Eur J Haematol. 1989 Apr;42(4):321–326. doi: 10.1111/j.1600-0609.1989.tb01219.x. [DOI] [PubMed] [Google Scholar]
  3. Borge O. J., Ramsfjell V., Cui L., Jacobsen S. E. Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+CD38- bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin. Blood. 1997 Sep 15;90(6):2282–2292. [PubMed] [Google Scholar]
  4. Buhr T., Georgii A., Schuppan O., Amor A., Kaloutsi V. Histologic findings in bone marrow biopsies of patients with thrombocythemic cell counts. Ann Hematol. 1992 Jun;64(6):286–291. doi: 10.1007/BF01695473. [DOI] [PubMed] [Google Scholar]
  5. Cerutti A., Custodi P., Duranti M., Noris P., Balduini C. L. Thrombopoietin levels in patients with primary and reactive thrombocytosis. Br J Haematol. 1997 Nov;99(2):281–284. doi: 10.1046/j.1365-2141.1997.3823196.x. [DOI] [PubMed] [Google Scholar]
  6. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  7. Columbyova L., Loda M., Scadden D. T. Thrombopoietin receptor expression in human cancer cell lines and primary tissues. Cancer Res. 1995 Aug 15;55(16):3509–3512. [PubMed] [Google Scholar]
  8. Debili N., Wendling F., Cosman D., Titeux M., Florindo C., Dusanter-Fourt I., Schooley K., Methia N., Charon M., Nador R. The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood. 1995 Jan 15;85(2):391–401. [PubMed] [Google Scholar]
  9. Georgii A., Buhr T., Buesche G., Kreft A., Choritz H. Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies. Leuk Lymphoma. 1996 Sep;22 (Suppl 1):15–29. doi: 10.3109/10428199609074357. [DOI] [PubMed] [Google Scholar]
  10. Georgii A., Vykoupil K. F., Thiele J. Chronic megakaryocytic granulocytic myelosis-CMGM. A subtype of chronic myeloid leukemia. Virchows Arch A Pathol Anat Histol. 1980;389(3):253–268. doi: 10.1007/BF00430654. [DOI] [PubMed] [Google Scholar]
  11. Gordon M. Y., Goldman J. M. Cellular and molecular mechanisms in chronic myeloid leukaemia: biology and treatment. Br J Haematol. 1996 Oct;95(1):10–20. [PubMed] [Google Scholar]
  12. Green A. R. Pathogenesis of polycythaemia vera. Lancet. 1996 Mar 30;347(9005):844–845. doi: 10.1016/s0140-6736(96)91338-0. [DOI] [PubMed] [Google Scholar]
  13. Hibbin J. A., Njoku O. S., Matutes E., Lewis S. M., Goldman J. M. Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders. Br J Haematol. 1984 Jul;57(3):495–503. doi: 10.1111/j.1365-2141.1984.tb02924.x. [DOI] [PubMed] [Google Scholar]
  14. Jacobsson S., Carneskog J., Ridell B., Wadenvik H., Swolin B., Kutti J. Flow cytometric analysis of megakaryocyte ploidy in chronic myeloproliferative disorders and reactive thrombocytosis. Eur J Haematol. 1996 May;56(5):287–292. doi: 10.1111/j.1600-0609.1996.tb00717.x. [DOI] [PubMed] [Google Scholar]
  15. Juvonen E., Ikkala E., Oksanen K., Ruutu T. Megakaryocyte and erythroid colony formation in essential thrombocythaemia and reactive thrombocytosis: diagnostic value and correlation to complications. Br J Haematol. 1993 Feb;83(2):192–197. doi: 10.1111/j.1365-2141.1993.tb08271.x. [DOI] [PubMed] [Google Scholar]
  16. Juvonen E., Partanen S., Ruutu T. Colony formation by megakaryocytic progenitors in essential thrombocythaemia. Br J Haematol. 1987 Jun;66(2):161–164. doi: 10.1111/j.1365-2141.1987.tb01293.x. [DOI] [PubMed] [Google Scholar]
  17. Kaloutsi V., Fritsch R. S., Buhr T., Restrepo-Specht I., Widjaja W., Georgii A. Megakaryocytes in chronic myeloproliferative disorders: numerical density correlated between different entities. Virchows Arch A Pathol Anat Histopathol. 1991;418(6):493–497. doi: 10.1007/BF01606498. [DOI] [PubMed] [Google Scholar]
  18. Kaushansky K., Lok S., Holly R. D., Broudy V. C., Lin N., Bailey M. C., Forstrom J. W., Buddle M. M., Oort P. J., Hagen F. S. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature. 1994 Jun 16;369(6481):568–571. doi: 10.1038/369568a0. [DOI] [PubMed] [Google Scholar]
  19. Kaushansky K. Thrombopoietin. N Engl J Med. 1998 Sep 10;339(11):746–754. doi: 10.1056/NEJM199809103391107. [DOI] [PubMed] [Google Scholar]
  20. Kobayashi S., Teramura M., Hoshino S., Motoji T., Oshimi K., Mizoguchi H. Circulating megakaryocyte progenitors in myeloproliferative disorders are hypersensitive to interleukin-3. Br J Haematol. 1993 Apr;83(4):539–544. doi: 10.1111/j.1365-2141.1993.tb04688.x. [DOI] [PubMed] [Google Scholar]
  21. Li Y., Hetet G., Kiladjian J. J., Gardin C., Grandchamp B., Briere J. Proto-oncogene c-mpl is involved in spontaneous megakaryocytopoiesis in myeloproliferative disorders. Br J Haematol. 1996 Jan;92(1):60–66. doi: 10.1046/j.1365-2141.1996.00297.x. [DOI] [PubMed] [Google Scholar]
  22. Methia N., Louache F., Vainchenker W., Wendling F. Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood. 1993 Sep 1;82(5):1395–1401. [PubMed] [Google Scholar]
  23. Moliterno A. R., Hankins W. D., Spivak J. L. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N Engl J Med. 1998 Feb 26;338(9):572–580. doi: 10.1056/NEJM199802263380903. [DOI] [PubMed] [Google Scholar]
  24. Nafe R., Georgii A., Kaloutsi V., Fritsch R. S., Choritz H. Planimetric analysis of megakaryocytes in the four main groups of chronic myeloproliferative disorders. Virchows Arch B Cell Pathol Incl Mol Pathol. 1991;61(2):111–116. doi: 10.1007/BF02890412. [DOI] [PubMed] [Google Scholar]
  25. Nolte M., Werner M., Ewig M., von Wasielewski R., Wilkens L., Georgii A. Demonstration of the Philadelphia translocation by fluorescence in situ hybridization (FISH) in paraffin sections and identification of aberrant cells by a combined FISH/immunophenotyping approach. Histopathology. 1995 May;26(5):433–437. doi: 10.1111/j.1365-2559.1995.tb00250.x. [DOI] [PubMed] [Google Scholar]
  26. Souyri M., Vigon I., Penciolelli J. F., Heard J. M., Tambourin P., Wendling F. A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors. Cell. 1990 Dec 21;63(6):1137–1147. doi: 10.1016/0092-8674(90)90410-g. [DOI] [PubMed] [Google Scholar]
  27. Ulich T. R., del Castillo J., Senaldi G., Kinstler O., Yin S., Kaufman S., Tarpley J., Choi E., Kirley T., Hunt P. Systemic hematologic effects of PEG-rHuMGDF-induced megakaryocyte hyperplasia in mice. Blood. 1996 Jun 15;87(12):5006–5015. [PubMed] [Google Scholar]
  28. Vigon I., Mornon J. P., Cocault L., Mitjavila M. T., Tambourin P., Gisselbrecht S., Souyri M. Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5640–5644. doi: 10.1073/pnas.89.12.5640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Yan X. Q., Lacey D., Hill D., Chen Y., Fletcher F., Hawley R. G., McNiece I. K. A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation. Blood. 1996 Jul 15;88(2):402–409. [PubMed] [Google Scholar]

Articles from Molecular Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES